Benzinga - Gainers
- Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50.
- Silvergate Capital Corporation (NYSE: SI) climbed 48% to $1.67 on rumor suggesting a crypto exchange is trying to buy Silvergate's trade processing technologies.
- Dermata Therapeutics, Inc. (NASDAQ: DRMA) gained 33.9% to $2.2499 after jumping 25% on Thursday. Maxim Group maintained Dermata Therapeutics with a Buy and lowered the price target from $16 to $4.
- NaaS Technology Inc. (NASDAQ: NAAS) jumped 25.7% to $5.24. NaaS Technology will hold an annual general meeting of shareholders on April 19, 2023.
- GH Research PLC (NASDAQ: GHRS) gained 25.5% to $8.68.
- Vaccitech plc (NASDAQ: VACC) climbed 25.4% to $2.8355 after the company reported better-than-expected FY22 sales results.
- Troika Media Group, Inc. (NASDAQ: TRKA) rose 23.4% to $0.2205.
- GD Culture Group Limited (NASDAQ: GDC) gained 22.8% to $3.2899.
- G Medical Innovations Holdings Ltd (NASDAQ: GMVD) jumped 21.5% to $2.09.
- Bird Global, Inc. (NYSE: BRDS) shares rose 19.3% to $0.1691 after gaining more than 17% on Thursday. Bird announced plans to expand across Greater Toronto area this spring.
- Torrid Holdings Inc. (NYSE: CURV) gained 18.1% to $2.81 after the company reported Q4 results.
- Vicarious Surgical Inc. (NYSE: RBOT) jumped 16% to $1.74.
- Usio, Inc. (NASDAQ: USIO) jumped 15.7% to $1.98.
- Xcel Brands, Inc. (NASDAQ: XELB) gained 14.5% to $0.70.
- Vor Biopharma Inc. (NASDAQ: VOR) jumped 13.7% to $5.80 following a narrower-than-expected quarterly loss.
- ReNew Energy Global Plc (NASDAQ: RNW) gained 13.6% to $4.99.
- Reading International, Inc. (NASDAQ: RDIB) surged 8% to $22.14.
- ADMA Biologics, Inc. (NASDAQ: ADMA) shares climbed 6.8% to $3.3215 after the company reported better-than-expected Q4 sales results and issued FY23 revenue guidance above estimates.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Boxed, Inc. (NYSE: BOXD) fell 35.8% to $0.2209 after gaining 91% on Thursday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankruptcy Code and other strategic alternatives.
- Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares dropped 32% to $0.0767 after the company announced a reverse stock split of its common stock.
- FiscalNote Holdings, Inc. (NYSE: NOTE) shares tumbled 29.4% to $1.6799. FiscalNote shares jumped 75% on Thursday after the company announced it was selected by OpenAI for collaboration as an inaugural launch partner for OpenAI's ChatGPT plug-in.
- Hyzon Motors Inc. (NASDAQ: HYZN) fell 25.4% to $0.7456.
- Scholastic Corporation (NASDAQ: SCHL) fell 23% to $31.82 after the company said Q3 adjusted EPS and sales results were lower year over year.
- YS Biopharma Co., Ltd. (NASDAQ: YS) dipped 22% to $10.14.
- Sentage Holdings Inc. (NASDAQ: SNTG) dropped 20.8% to $2.05.
- DiamondHead Holdings Corp. (NASDAQ: DHHC) fell 19.8% to $15.15 after gaining more than 82% on Thursday. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.
- Cidara Therapeutics, Inc. (NASDAQ: CDTX) dropped 17.7% to $1.1750. HC Wainwright & Co. reiterated Cidara Therapeutics with a Buy and maintained a $6 price target.
- Baosheng Media Group Holdings Limited (NASDAQ: BAOS) fell 17.7% to $3.53.
- Express, Inc. (NYSE: EXPR) fell 16.2% to $0.7122 after the company reported worse-than-expected Q4 sales results.
- Flora Growth Corp. (NASDAQ: FLGC) fell 15.4% to $0.2360. Flora Growth is expected to host its 2022 year-end earnings call on Monday, April 3, 2023.
- SMX (Security Matters) Public Limited Company (NASDAQ: SMX) shares fell 14.2% to $1.10 after jumping over 35% on Thursday.
- Oxford Industries, Inc. (NYSE: OXM) dropped 13.2% to $101.06 after the company issued Q1 adjusted EPS guidance below estimates.
- Ouster, Inc. (NYSE: OUST) fell 12.5% to $0.7909 after the company reported downbeat Q4 results and issued weak Q1 sales forecast.
- PepGen Inc. (NASDAQ: PEPG) fell 12.3% to $14.79 following Q4 results.
- Invivyd, Inc. (NASDAQ: IVVD) dropped 11.2% to $1.2685. Invivyd posted a FY22 loss of $2.23 per share.
- Lilium N.V. (NASDAQ: LILM) fell 10.8% to $0.7089.
- Heron Therapeutics, Inc. (NASDAQ: HRTX) fell 10.7% to $1.8450 after posting Q4 results.
- Proterra Inc. (NASDAQ: PTRA) dropped 10.1% to $1.5199.
- PARTS iD, Inc. (NYSE: ID) fell 8.6% to $0.2146.
- Farfetch Limited (NYSE: FTCH) fell 7% to $4.3450. Citigroup maintained Farfetch with a Sell and lowered the price target from $6 to $4.
- Getty Images Holdings, Inc. (NYSE: GETY) fell 6.9% to $3.75.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.